Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells

por Meira, D D, de Almeida, V H, Mororó, J S, Nóbrega, I, Bardella, L, Silva, R L A, Albano, R M, Ferreira, C G
Publicado 2009

Epidermal growth factor receptor regulates fibrinolytic pathway elements in cervical cancer: functional and prognostic implications

por Gomes, F.G., Almeida, V.H., Martins-Cardoso, K., Martins-Dinis, M.M.D.C., Rondon, A.M.R., de Melo, A.C., Tilli, T.M., Monteiro, R.Q.
Publicado 2021

Radiotherapy modulates expression of EGFR, ERCC1 and p53 in cervical cancer

por de Almeida, V.H., de Melo, A.C., Meira, D.D., Pires, A.C., Nogueira-Rodrigues, A., Pimenta-Inada, H.K., Alves, F.G., Moralez, G., Thiago, L.S., Ferreira, C.G., Sternberg, C.
Publicado 2017